CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Carlotta Granchi

ORCID: 0000-0002-5849-0722↗

Public evidence

6 connected articles

Recent Progress in the Development of Selective MAGL Modulators (2020-2026).2026 · PubMed Central Open Access Methods for Assessing MAGL Enzymatic Activity: An Extensive Review of Past and Emerging Approaches.2025 · Europe PMC Identification of a Possible Endocannabinoid-Mediated Mechanism of Action of Cetylated Fatty Acids.2025 · Europe PMC α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases.2021 · Europe PMC Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.2020 · Europe PMC Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.2017 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Carlotta Granchi - Medical Cannabis Research Engine